These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clozapine in the management of schizophrenia. Risperidone is less toxic but equally effective. Menkes DB BMJ; 1993 Jul; 307(6897):200. PubMed ID: 7688254 [No Abstract] [Full Text] [Related]
23. Recent developments in antipsychotic therapy. Introduction. Love RC Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S3-4. PubMed ID: 7538436 [No Abstract] [Full Text] [Related]
24. Unexpected dystonia while changing from clozapine to risperidone. Radford JM; Brown TM; Borison RL J Clin Psychopharmacol; 1995 Jun; 15(3):225-6. PubMed ID: 7543499 [No Abstract] [Full Text] [Related]
25. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. Jacobsen FM J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159 [TBL] [Abstract][Full Text] [Related]
26. Neuroleptic sensitivity to risperidone in Lewy body dementia. McKeith IG; Ballard CG; Harrison RW Lancet; 1995 Sep; 346(8976):699. PubMed ID: 7544860 [No Abstract] [Full Text] [Related]
27. Effects of concomitant risperidone and lithium treatment. Swanson CL; Price WA; McEvoy JP Am J Psychiatry; 1995 Jul; 152(7):1096. PubMed ID: 7540798 [No Abstract] [Full Text] [Related]
28. Risperidone: clinical development: north American results. Marder SR Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():92A-93A. PubMed ID: 1379883 [TBL] [Abstract][Full Text] [Related]
29. Risperidone: clinical issues in treatment. Littrell K; Schultz RE J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):47-9. PubMed ID: 7519677 [No Abstract] [Full Text] [Related]
32. Novel neuroleptics in schizophrenia: theory and clinical relevance. Remington GJ Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050 [No Abstract] [Full Text] [Related]
33. Risperidone (R64 766) in psychotic patients. A first clinical therapeutic exploration. Roose K; Gelders Y; Heylen S Acta Psychiatr Belg; 1988; 88(3):233-41. PubMed ID: 2466393 [TBL] [Abstract][Full Text] [Related]
34. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. Kopala L; Honer WG Am J Psychiatry; 1994 Nov; 151(11):1714-5. PubMed ID: 7524373 [No Abstract] [Full Text] [Related]
35. New advances in the treatment of schizophrenia. Introduction. Potkin SG J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S1-3. PubMed ID: 18334907 [No Abstract] [Full Text] [Related]
36. New drugs: asenapine, iloperidone, and bepotastine besilate. Hussar DA; Abbas CA J Am Pharm Assoc (2003); 2010; 50(1):107-10. PubMed ID: 20097650 [No Abstract] [Full Text] [Related]
37. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses. Cesková E; Svestka J Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306 [TBL] [Abstract][Full Text] [Related]
38. Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective study. Addington DE; Jones B; Bloom D; Chouinard G; Remington G; Albright P Clin Ther; 1993; 15(5):917-26. PubMed ID: 7505716 [TBL] [Abstract][Full Text] [Related]
39. Priapism associated with iloperidone: a case report. Rodriguez-Cabezas LA; Kong BY; Agarwal G Gen Hosp Psychiatry; 2014; 36(4):451.e5-6. PubMed ID: 24726763 [TBL] [Abstract][Full Text] [Related]